Malaysia Biologics Market (2024-2030) | Companies, Industry, Analysis, Revenue, Forecast, Growth, Size, Share, Outlook, Value & Trends

Market Forecast By Source (Microbial, Mammalian, Others), By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy, Others), By Diseaseย  Category (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others), By Biologics Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC052446 Publication Date: Jun 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Malaysia Biologics Market Synopsis

The biologics market in Malaysia is expected to grow at a CAGR of 8.9% during the forecast period 2020-2026. The major factors driving the growth of the Malaysia biologics market include increasing patient awareness and knowledge about better therapeutic options, rising prevalence of chronic diseases such as cancer and diabetes, rising healthcare expenditure by public bodies, growing demand for advanced therapies like monoclonal antibodies, introduction of innovative technologies in drug manufacturing processes and increasing government initiatives towards improving access to treatment with high cost drugs

In addition to this, certain restraints such as lack of reimbursement policies leading to high costs for patients are expected to be experienced by this market over the next few years. However, companies operating in this space are continuously investing in R&D activities for development of biosimilars that can offer similar therapeutic effects at lower prices than those offered by branded counterparts; thus helping them gain an edge over their competitors. This trend is expected to support the expansion plans undertaken by various stakeholders present within this landscape over the coming years

Key Highlights of the Report:

  • Malaysia Biologics Market Outlook
  • Market Size of Malaysia Biologics Market, 2023
  • Forecast of Malaysia Biologics Market, 2030
  • Historical Data and Forecast of Malaysia Biologics Revenues & Volume for the Period 2020-2030
  • Malaysia Biologics Market Trend Evolution
  • Malaysia Biologics Market Drivers and Challenges
  • Malaysia Biologics Price Trends
  • Malaysia Biologics Porter's Five Forces
  • Malaysia Biologics Industry Life Cycle
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Source for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Microbial for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Mammalian for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Product Type for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Monoclonal Antibodies for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Vaccines for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Recombinant Proteins for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Antisense, RNAi, & Molecular Therapy for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Disease? Category for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Oncology for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Infectious Diseases for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Immunological Disorders for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Cardiovascular Disorders for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Hematological Disorders for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Others for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Biologics Manufacturing for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By Outsourced for the Period 2020-2030
  • Historical Data and Forecast of Malaysia Biologics Market Revenues & Volume By In-house for the Period 2020-2030
  • Malaysia Biologics Import Export Trade Statistics
  • Market Opportunity Assessment By Source
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Disease? Category
  • Market Opportunity Assessment By Biologics Manufacturing
  • Malaysia Biologics Top Companies Market Share
  • Malaysia Biologics Competitive Benchmarking By Technical and Operational Parameters
  • Malaysia Biologics Company Profiles
  • Malaysia Biologics Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Malaysia Biologics Market Overview

3.1 Malaysia Country Macro Economic Indicators

3.2 Malaysia Biologics Market Revenues & Volume, 2020 & 2030F

3.3 Malaysia Biologics Market - Industry Life Cycle

3.4 Malaysia Biologics Market - Porter's Five Forces

3.5 Malaysia Biologics Market Revenues & Volume Share, By Source, 2020 & 2030F

3.6 Malaysia Biologics Market Revenues & Volume Share, By Product Type, 2020 & 2030F

3.7 Malaysia Biologics Market Revenues & Volume Share, By Diseaseย  Category, 2020 & 2030F

3.8 Malaysia Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2020 & 2030F

4 Malaysia Biologics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Malaysia Biologics Market Trends

6 Malaysia Biologics Market, By Types

6.1 Malaysia Biologics Market, By Source

6.1.1 Overview and Analysis

6.1.2 Malaysia Biologics Market Revenues & Volume, By Source, 2020-2030F

6.1.3 Malaysia Biologics Market Revenues & Volume, By Microbial, 2020-2030F

6.1.4 Malaysia Biologics Market Revenues & Volume, By Mammalian, 2020-2030F

6.1.5 Malaysia Biologics Market Revenues & Volume, By Others, 2020-2030F

6.2 Malaysia Biologics Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 Malaysia Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2020-2030F

6.2.3 Malaysia Biologics Market Revenues & Volume, By Vaccines, 2020-2030F

6.2.4 Malaysia Biologics Market Revenues & Volume, By Recombinant Proteins, 2020-2030F

6.2.5 Malaysia Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2020-2030F

6.2.6 Malaysia Biologics Market Revenues & Volume, By Others, 2020-2030F

6.3 Malaysia Biologics Market, By Diseaseย  Category

6.3.1 Overview and Analysis

6.3.2 Malaysia Biologics Market Revenues & Volume, By Oncology, 2020-2030F

6.3.3 Malaysia Biologics Market Revenues & Volume, By Infectious Diseases, 2020-2030F

6.3.4 Malaysia Biologics Market Revenues & Volume, By Immunological Disorders, 2020-2030F

6.3.5 Malaysia Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2020-2030F

6.3.6 Malaysia Biologics Market Revenues & Volume, By Hematological Disorders, 2020-2030F

6.3.7 Malaysia Biologics Market Revenues & Volume, By Others, 2020-2030F

6.4 Malaysia Biologics Market, By Biologics Manufacturing

6.4.1 Overview and Analysis

6.4.2 Malaysia Biologics Market Revenues & Volume, By Outsourced, 2020-2030F

6.4.3 Malaysia Biologics Market Revenues & Volume, By In-house, 2020-2030F

7 Malaysia Biologics Market Import-Export Trade Statistics

7.1 Malaysia Biologics Market Export to Major Countries

7.2 Malaysia Biologics Market Imports from Major Countries

8 Malaysia Biologics Market Key Performance Indicators

9 Malaysia Biologics Market - Opportunity Assessment

9.1 Malaysia Biologics Market Opportunity Assessment, By Source, 2020 & 2030F

9.2 Malaysia Biologics Market Opportunity Assessment, By Product Type, 2020 & 2030F

9.3 Malaysia Biologics Market Opportunity Assessment, By Diseaseย  Category, 2020 & 2030F

9.4 Malaysia Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2020 & 2030F

10 Malaysia Biologics Market - Competitive Landscape

10.1 Malaysia Biologics Market Revenue Share, By Companies, 2023

10.2 Malaysia Biologics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All